vs

Side-by-side financial comparison of FIVE BELOW, INC (FIVE) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $1.0B, roughly 1.4× FIVE BELOW, INC). ResMed runs the higher net margin — 27.6% vs 3.5%, a 24.1% gap on every dollar of revenue. On growth, FIVE BELOW, INC posted the faster year-over-year revenue change (23.1% vs 11.0%). Over the past eight quarters, ResMed's revenue compounded faster (7.8% CAGR vs -11.9%).

Five Below, Inc. is an American chain of specialty discount gift shops that prices most of its products at up to $5, plus a smaller assortment of products priced up to $40. Founded in 2002 by Tom Vellios and David Schlessinger and headquartered in Philadelphia, Pennsylvania, the chain is aimed at tweens and teens. By 2014, there were more than 1,850 stores located across the United States.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

FIVE vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.4× larger
RMD
$1.4B
$1.0B
FIVE
Growing faster (revenue YoY)
FIVE
FIVE
+12.1% gap
FIVE
23.1%
11.0%
RMD
Higher net margin
RMD
RMD
24.1% more per $
RMD
27.6%
3.5%
FIVE
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.8%
-11.9%
FIVE

Income Statement — Q3 FY2026 vs Q4 FY2026

Metric
FIVE
FIVE
RMD
RMD
Revenue
$1.0B
$1.4B
Net Profit
$36.5M
$392.6M
Gross Margin
33.8%
61.8%
Operating Margin
4.2%
34.6%
Net Margin
3.5%
27.6%
Revenue YoY
23.1%
11.0%
Net Profit YoY
2063.9%
13.9%
EPS (diluted)
$0.66
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FIVE
FIVE
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$1.0B
$1.4B
Q3 25
$1.0B
$1.3B
Q2 25
$970.5M
$1.3B
Q1 25
$1.4B
$1.3B
Q4 24
$843.7M
$1.3B
Q3 24
$830.1M
$1.2B
Net Profit
FIVE
FIVE
RMD
RMD
Q2 26
$392.6M
Q1 26
$398.7M
Q4 25
$36.5M
$392.6M
Q3 25
$42.8M
$348.5M
Q2 25
$41.1M
$379.7M
Q1 25
$187.5M
$365.0M
Q4 24
$1.7M
$344.6M
Q3 24
$33.0M
$311.4M
Gross Margin
FIVE
FIVE
RMD
RMD
Q2 26
61.8%
Q1 26
62.2%
Q4 25
33.8%
61.8%
Q3 25
33.3%
61.5%
Q2 25
33.4%
60.8%
Q1 25
40.2%
59.3%
Q4 24
30.6%
58.6%
Q3 24
32.7%
58.6%
Operating Margin
FIVE
FIVE
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
4.2%
34.6%
Q3 25
5.1%
33.4%
Q2 25
5.2%
33.7%
Q1 25
17.7%
33.0%
Q4 24
-0.1%
32.5%
Q3 24
5.0%
31.6%
Net Margin
FIVE
FIVE
RMD
RMD
Q2 26
27.6%
Q1 26
27.9%
Q4 25
3.5%
27.6%
Q3 25
4.2%
26.1%
Q2 25
4.2%
28.2%
Q1 25
13.5%
28.3%
Q4 24
0.2%
26.9%
Q3 24
4.0%
25.4%
EPS (diluted)
FIVE
FIVE
RMD
RMD
Q2 26
$2.68
Q1 26
$2.74
Q4 25
$0.66
$2.68
Q3 25
$0.77
$2.37
Q2 25
$0.75
$2.58
Q1 25
$3.40
$2.48
Q4 24
$0.03
$2.34
Q3 24
$0.60
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FIVE
FIVE
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$524.5M
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$2.0B
$6.3B
Total Assets
$4.8B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FIVE
FIVE
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.7B
Q4 25
$524.5M
$1.4B
Q3 25
$670.2M
$1.4B
Q2 25
$624.0M
$1.2B
Q1 25
$528.8M
$932.7M
Q4 24
$216.6M
$521.9M
Q3 24
$327.7M
$426.4M
Total Debt
FIVE
FIVE
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
Q3 24
$667.6M
Stockholders' Equity
FIVE
FIVE
RMD
RMD
Q2 26
$6.3B
Q1 26
$6.5B
Q4 25
$2.0B
$6.3B
Q3 25
$1.9B
$6.1B
Q2 25
$1.9B
$6.0B
Q1 25
$1.8B
$5.5B
Q4 24
$1.6B
$5.3B
Q3 24
$1.6B
$5.2B
Total Assets
FIVE
FIVE
RMD
RMD
Q2 26
$8.5B
Q1 26
$8.8B
Q4 25
$4.8B
$8.5B
Q3 25
$4.6B
$8.3B
Q2 25
$4.5B
$8.2B
Q1 25
$4.3B
$7.6B
Q4 24
$4.2B
$7.1B
Q3 24
$4.0B
$7.2B
Debt / Equity
FIVE
FIVE
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FIVE
FIVE
RMD
RMD
Operating Cash FlowLast quarter
$-80.1M
Free Cash FlowOCF − Capex
$-133.2M
FCF MarginFCF / Revenue
-12.8%
Capex IntensityCapex / Revenue
5.1%
Cash ConversionOCF / Net Profit
-2.19×
TTM Free Cash FlowTrailing 4 quarters
$323.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FIVE
FIVE
RMD
RMD
Q2 26
Q1 26
Q4 25
$-80.1M
$339.7M
Q3 25
$93.0M
$457.3M
Q2 25
$132.7M
$538.8M
Q1 25
$363.5M
$578.7M
Q4 24
$-30.6M
$308.6M
Q3 24
$71.3M
$325.5M
Free Cash Flow
FIVE
FIVE
RMD
RMD
Q2 26
Q1 26
Q4 25
$-133.2M
$311.2M
Q3 25
$48.3M
$414.4M
Q2 25
$96.5M
$508.2M
Q1 25
$311.4M
$557.9M
Q4 24
$-111.0M
$288.0M
Q3 24
$-32.4M
$307.7M
FCF Margin
FIVE
FIVE
RMD
RMD
Q2 26
Q1 26
Q4 25
-12.8%
21.9%
Q3 25
4.7%
31.0%
Q2 25
9.9%
37.7%
Q1 25
22.4%
43.2%
Q4 24
-13.2%
22.5%
Q3 24
-3.9%
25.1%
Capex Intensity
FIVE
FIVE
RMD
RMD
Q2 26
Q1 26
Q4 25
5.1%
2.0%
Q3 25
4.4%
3.2%
Q2 25
3.7%
2.3%
Q1 25
3.7%
1.6%
Q4 24
9.5%
1.6%
Q3 24
12.5%
1.5%
Cash Conversion
FIVE
FIVE
RMD
RMD
Q2 26
Q1 26
Q4 25
-2.19×
0.87×
Q3 25
2.17×
1.31×
Q2 25
3.22×
1.42×
Q1 25
1.94×
1.59×
Q4 24
-18.13×
0.90×
Q3 24
2.16×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons